X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Market Moves

New Zenytime “Puck” Is First Bluetooth Device That Allows Users to Play Games and Reduce Stress Using Only Their Breath

Yuvraj_pawp by Yuvraj_pawp
4th September 2014
in Market Moves

Now available for pre-order, unique patented sensor allows Zenytime users to practice conscious breathing while playing games on their smartphone or tablet.

 

Zenytime, a technology company on a mission to help people reduce stress and feel better using their breath, today announced its pre-ordering campaign to introduce its first consumer product, a wellness connected device that turns breathing into game controls. The games coaches users to do healthful breathing exercises on their smartphones or tablets.

 

Zenytime is the first device designed to help users improve their well-being by playing mobile games using only their breath. Mixing self-improvement and gamification, it promotes serenity, clarity and energy for busy minds and bodies in just a few breaks a day. It is not a wearable device but rather a small companion that fits in pocket, purse, bag, keychain or any carry-on.

 

The Zenytime solution enables gaming apps to act as breathing coaches thanks to a Bluetooth accessory called “the Puck” which features an exclusive patented sensor that tracks controlled breathing and translates it into game controls. To deliver a comprehensive experience, the Puck also captures heart rate and blood oxygen levels. It integrates Bluetooth 4.0 for long battery life and seamless connection with iOS and Android mobile platforms.

 

Zenytime games are founded on scientifically proven breathing patterns for improving stress management, cardiovascular health and cognitive and athletic performance. The Zenytime dashboard provides stats, tips and rewards toward a healthier you.

 

“Our games have been designed to promote deep, rhythmic breathing to bring more oxygen into your cells and to trigger the many short-term rewards of controlled breathing,” said co-founder Celine Vignal. “Zenytime games are adapted to people of any age, as well as exercise enthusiasts and professional athletes.”

 

The Zenytime team is helped by highly qualified advisors, including Dr. Melissa Conrad Stöppler, recipient of a Physician Scientist Award from the U.S. National Cancer Institute; Dr. Jim Taylor, an internationally-recognized authority on the psychology of performance in business and sport; and Ultramarathon Man Dean Karnazes, named one of the “Top 100 Most Influential People in the World” by TIME magazine.

 

Zenytime is currently developing games with key players in complementary industries such as yoga, fitness, sports and wellness. Designed to respond to specific interests, branded games will mix partners’ expertise and Zenytime’s competencies, and will be available for free to all Zenytime users.

 

Zenytime is priced at $99 but is available at $79 during the pre-order period with free shipping in the US and Canada. Shipping expected in the winter, 2014/2015.

SOURCE Zenytime

Previous Post

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

Next Post

Bayer seeks marketing authorisation of aflibercept solution for injection in Japan

Related Posts

Featured

SVB Collapse And Its Implications On Biotechnology Sector

18th March 2023
Featured

US President Looks To Double The Drugs For Price Negotiation

18th March 2023
$118bn Sales By 2026 Is What Japanese Pharma Can Expect
Featured

$118bn Sales By 2026 Is What Japanese Pharma Can Expect

2nd March 2023
Featured

Bioavailability Enhancement Market Projects CAGR of 11%

28th February 2023
Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m
Market Moves

Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m

18th July 2022
Could The Long Deckline In Biotechnology M&A Be Ending
Featured

Could The Long Deckline In Biotechnology M&A Be Ending

16th July 2022
Next Post

Bayer seeks marketing authorisation of aflibercept solution for injection in Japan

Latest News

Drug Development

New Delivery Path Brings To Light Efficacy of Immunotherapy

1st April 2023
Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In